These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9761127)

  • 21. CD44 expression is associated with increased survival in node-negative invasive breast carcinoma.
    Diaz LK; Zhou X; Wright ET; Cristofanilli M; Smith T; Yang Y; Sneige N; Sahin A; Gilcrease MZ
    Clin Cancer Res; 2005 May; 11(9):3309-14. PubMed ID: 15867228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of CD44v5 expression in human thymic epithelial neoplasms.
    Lee SC; Harn HJ; Lin TS; Yeh KT; Liu YC; Tsai CS; Cheng YL
    Ann Thorac Surg; 2003 Jul; 76(1):213-8; discussion 218. PubMed ID: 12842543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prognostic value of CD44 isoforms in prostate cancer patients treated by radical prostatectomy.
    Noordzij MA; van Steenbrugge GJ; Verkaik NS; Schröder FH; van der Kwast TH
    Clin Cancer Res; 1997 May; 3(5):805-15. PubMed ID: 9815753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Expression tumor stem cell surface marker CD44 in gastric cancer and its significance].
    Xie JW; Huang CM; Zheng CH; Li P; Wang JB; Lin JX; Lu J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Nov; 16(11):1107-12. PubMed ID: 24277411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
    Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
    Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of immunohistochemically detected CD44 expression in patients with carcinoma of the vulva.
    Tempfer C; Gitsch G; Haeusler G; Reinthaller A; Koelbl H; Kainz C
    Cancer; 1996 Jul; 78(2):273-7. PubMed ID: 8674003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of CD44 splice variants in human stage III cervical cancer.
    Kainz C; Kohlberger P; Tempfer C; Sliutz G; Gitsch G; Reinthaller A; Breitenecker G
    Eur J Cancer; 1995 Sep; 31A(10):1706-9. PubMed ID: 7488429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential clinical relevance of uPA and PAI-1 levels in node-negative, postmenopausal breast cancer patients bearing histological grade II tumors with ER/PR expression, during an early follow-up.
    Buta M; Džodić R; Đurišić I; Marković I; Vujasinović T; Markićević M; Nikolić-Vukosavljević D
    Tumour Biol; 2015 Sep; 36(10):8193-200. PubMed ID: 25994573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prognostic value of estrogen and progesterone receptors in the operable breast cancer: results of a uni- and multifactorial analysis].
    Chevallier B; Heintzman F; Asselain B; Dauce JP; Bastit P; Graic Y; Brunelle P; Basuyau JP; Comoz M
    Bull Cancer; 1988; 75(1):23-36. PubMed ID: 3359056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of angiogenesis, laminin and CD44 expression in metastatic behavior of early-stage low-grade invasive breast carcinomas.
    Ozer E; Canda T; Kurtodlu B
    Cancer Lett; 1997 Dec; 121(2):119-23. PubMed ID: 9570348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasminogen activator inhibitor-1 and prognosis in primary breast cancer.
    Foekens JA; Schmitt M; van Putten WL; Peters HA; Kramer MD; Jänicke F; Klijn JG
    J Clin Oncol; 1994 Aug; 12(8):1648-58. PubMed ID: 8040677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD44 exon 6 expression as a possible early prognostic factor in primary node negative breast carcinoma.
    Guriec N; Marcellin L; Gairard B; Caldéroli H; Wilk A; Renaud R; Bergerat JP; Oberling F
    Clin Exp Metastasis; 1996 Oct; 14(5):434-9. PubMed ID: 8871537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer.
    Friedrichs K; Franke F; Lisboa BW; Kügler G; Gille I; Terpe HJ; Hölzel F; Maass H; Günthert U
    Cancer Res; 1995 Nov; 55(22):5424-33. PubMed ID: 7585612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histologic grade and CD44 are independent predictors of axillary lymph node invasion in early (T1) breast cancer.
    Schneider J; Pollán M; Ruibal A; Jiménez E; Lucas AR; Núñez MI; Sánchez J; Tejerina A
    Tumour Biol; 1999; 20(6):319-30. PubMed ID: 10567878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression and prognostic value Of CD44 isoforms in nephroblastoma (Wilms tumor).
    Ghanem MA; Van Steenbrugge GJ; Van Der Kwast TH; Sudaryo MK; Noordzij MA; Nijman RJ
    J Urol; 2002 Aug; 168(2):681-6. PubMed ID: 12131349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Expression of adhesive molecule CD44v6 and p53 gene in breast cancer tissues and its relation with DNA ploidy].
    Zuo WS; Wei L; Wang XW; Wang YS; Yu ZY
    Ai Zheng; 2004 Nov; 23(11 Suppl):1418-22. PubMed ID: 15566648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patients.
    Kassem L; Deygas M; Fattet L; Lopez J; Goulvent T; Lavergne E; Chabaud S; Carrabin N; Chopin N; Bachelot T; Gillet G; Treilleux I; Rimokh R
    BMC Cancer; 2015 Jun; 15():453. PubMed ID: 26040677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prognostic significance of CD44s and CD44v6 expression in stage two breast carcinoma: an immunohistochemical study.
    Morris SF; O'Hanlon DM; McLaughlin R; McHale T; Connolly GE; Given HF
    Eur J Surg Oncol; 2001 Sep; 27(6):527-31. PubMed ID: 11520083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Expression and clinical significance of adhesive molecule CD44v6 in breast invasive ductal carcinoma].
    Lian ZQ; Yang MT; Hou JH; Luo RZ; Wang X; Tang J
    Ai Zheng; 2006 Oct; 25(10):1291-5. PubMed ID: 17059779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of chemotactic factor receptor 5 gene with breast cancer.
    Zhang Y; Meng FY; Li WL; Zhou CX; Guan Z; Fan HY
    Genet Mol Res; 2013 Nov; 12(4):5289-300. PubMed ID: 24301790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.